Access cutting-edge duchenne muscular dystrophy treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access duchenne muscular dystrophy specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related duchenne muscular dystrophy treatment provided free
This is a Phase 1/2 study of Multiple-Ascending Dose (MAD) levels for 12 weeks of treatment followed by 24 weeks of open-label treatment with a selected dose of NS-050/NCNP-03 administered once weekly to ambulant boys with DMD, who have a DMD exon deletion amenable to exon 50 skipping.
Sponsor: NS Pharma, Inc.
Check if you qualify for this duchenne muscular dystrophy clinical trial in Chicago, IL
If you're searching for duchenne muscular dystrophy treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced duchenne muscular dystrophy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.